NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS | Note 21

21. Revenue
21.1
  Group  Company 
  2021 
R’000 
2020 
R’000 
2021 
R’000 
2020 
R’000 
Revenue from sale of goods 2 437 065 1 884 589
Revenue from services 5 637 353 4 534 323
Administration fees 1 553 456 1 552 055
Health risk management fees – Medical aid schemes 1 427 354 1 218 151
Health risk management fees – Capitation funds 1 877 580 1 011 817
Management fees 4 053 17 914
IT revenue and other 541 974 496 606
Marketing fees 194 840 209 757
Healthcare insurance 38 096 28 023
Total revenue from contracts with customers 8 074 418 6 418 912
21.2 Disaggregation of revenue from contracts with customers
  In the following table, revenue from contracts with customers is disaggregated by primary geographical market, major products and service lines and timing of revenue recognition. The table also includes a reconciliation of the disaggregated revenue with the group/company’s reportable segments (see Note 5).
  Group
  Administration
fees
Health risk
management
fees –
medical aid
schemes
Management
fees
Healthcare
insurance
IT
revenue
and
other
Retail
Health risk
management
fees –
Capitation
funds
Marketing
fees
Group
total
  R’000 R’000 R’000 R’000 R’000 R’000 R’000 R’000 R’000
Revenue for the year ended 30 June 2021 disaggregated by type of goods or services – Group                
Primary geographical markets                  
South Africa 1 387 629 1 411 066 2 474 38 096 528 300 2 437 065 1 877 580 194 840 7 877 050
Africa 165 827 16 288 1 579 13 674 197 368
  1 553 456 1 427 354 4 053 38 096 541 974 2 437 065 1 877 580 194 840 8 074 418
Major product/ service line                          
Admin health 1 553 456 541 974 194 840 2 290 270
Retail (Pharma) 2 437 065 2 437 065
Managed healthcare 1 427 354 4 053 38 096 1 877 580 3 347 083
  1 553 456 1 427 354 4 053 38 096 541 974 2 437 065 1 877 580 194 840 8 074 418
Timing of revenue recognition                  
Products transferred at a point in time 2 437 065 2 437 065
Products and services transferred over time 1 553 456 1 427 354 4 053 38 096 541 974 1 877 580 194 840 5 637 353
  1 553 456 1 427 354 4 053 38 096 541 974 2 437 065 1 877 580 194 840 5 637 353
  Group
  Administration
fees
Health risk
management
fees –
medical aid
schemes
Management
fees
Healthcare
insurance
IT
revenue
and
other
Retail
Health risk
management
fees –
Capitation
funds
Marketing
fees
Group
total
  R’000 R’000 R’000 R’000 R’000 R’000 R’000 R’000 R’000
Revenue for the year ended 30 June 2020 disaggregated by type of goods or services – Group
Primary geographical markets                  
South Africa 1 392 593 1 202 093 16 320 28 023 485 356 1 884 589 1 011 817 209 757 6 230 548
Africa 159 462 16 058 1 594 11 250 188 364
  1 552 055 1 218 151 17 914 28 023 496 606 1 884 589 1 011 817 209 757 6 418 912
Major product/ service line                  
Admin health 1 552 055 496 606 1 011 817 209 757 3 270 235
Retail (Pharma) 1 884 589 1 884 589
Managed healthcare 1 218 151 17 914 28 023 1 264 088
  1 552 055 1 218 151 17 914 28 023 496 606 1 884 589 1 011 817 209 757 6 418 912
Timing of revenue recognition                  
Products transferred at a point in time 1 884 589 1 884 589
Products and services transferred over time 1 552 055 1 218 151 17 914 28 023 496 606 1 011 817 209 757 4 534 323
  1 552 055 1 218 151 17 914 28 023 496 606 1 884 589 1 011 817 209 757 6 418 912
21.3 Contract balances
  The following table provides information about receivables from contracts with customers.
   Group  Company 
   2021 
R’000 
2020 
R’000 
2021 
R’000 
2020 
R’000 
Current contract receivables        
Trade receivables 405 917  448 874 
Contract assets (18 818) (35 262) –  – 
Trade receivables impairment 387 099  413 612 
 

Performance obligations and revenue recognition policies

Revenue is measured based on the consideration specified in a contract with a customer. The Group recognises revenue when it transfers control over a good or for services rendered, once the performance obligation of the service is satisfied.

The table in Note 1(n)(i) provides information about the nature and timing of the satisfaction of performance obligations in contracts with customers, including significant payment terms, and the related revenue recognition policies.

All contracts within the Group have a single performance obligation hence the allocation of transaction price is not required.

   

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS | Note 21